DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Bicnu (Carmustine) - Acute Myeloid Leukaemia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Acute Myeloid Leukaemia (3)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Bicnu (Carmustine) where reactions include acute myeloid leukaemia. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Bicnu side effects in 60 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-09

Patient: 60 year old female

Reactions: Myelofibrosis, Acute Myeloid Leukaemia, Myelodysplastic Syndrome, Idiopathic Thrombocytopenic Purpura

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Alkeran
    Dosage: intravenous (not otherwise specified)
    Indication: Multiple Myeloma

Bicnu
    Dosage: intravenous (not otherwise specified)
    Indication: Multiple Myeloma

Cyclophosphamide
    Dosage: intravenous (not otherwise specified)
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: 4 years, intravenous (not otherwise specified)
    Indication: Multiple Myeloma

Doxorubicin Hydrochloride
    Dosage: intravenous (not otherwise specified)
    Indication: Multiple Myeloma

Prednisone
    Dosage: intravenous (not otherwise specified)
    Indication: Multiple Myeloma

Velcade
    Dosage: intravenous (not otherwise specified)
    Indication: Multiple Myeloma
    Start date: 2008-05-05

Velcade
    Dosage: intravenous (not otherwise specified)
    Indication: Multiple Myeloma
    Start date: 2008-05-19

Velcade
    Dosage: intravenous (not otherwise specified)
    Indication: Multiple Myeloma
    Start date: 2008-04-08

Vepesid
    Dosage: intravenous (not otherwise sepcified)
    Indication: Multiple Myeloma

Vincristine Sulfate
    Dosage: intravenous (not otherwise specified)
    Indication: Multiple Myeloma

Other drugs received by patient: Neupogen; Corticosteroids



Possible Bicnu side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-01

Patient: female

Reactions: Acute Myeloid Leukaemia, Myelodysplastic Syndrome

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Alkeran
    Indication: Multiple Myeloma
    Start date: 2000-01-01
    End date: 2000-01-01

Bicnu
    Indication: Multiple Myeloma
    Start date: 2000-01-01
    End date: 2000-01-01

Cyclophosphamide
    Indication: Multiple Myeloma
    Start date: 2000-01-01
    End date: 2000-01-01

Dexamethasone
    Start date: 2008-04-08

Dexamethasone
    Start date: 2008-06-01
    End date: 2008-01-01

Dexamethasone
    Indication: Multiple Myeloma
    Start date: 2008-05-05

Dexamethasone
    Start date: 2008-05-19

Doxorubicin Hydrochloride
    Indication: Multiple Myeloma
    Start date: 2000-01-01
    End date: 2000-01-01

Prednisone
    Indication: Multiple Myeloma
    Start date: 2000-01-01
    End date: 2000-01-01

Velcade
    Indication: Multiple Myeloma
    Start date: 2008-04-08
    End date: 2008-09-01

Vepesid
    Indication: Multiple Myeloma
    Start date: 2000-01-01
    End date: 2000-01-01

Vincristine
    Indication: Multiple Myeloma
    Start date: 2000-01-01
    End date: 2000-01-01



Possible Bicnu side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-01

Patient: female

Reactions: Acute Myeloid Leukaemia, Myelodysplastic Syndrome

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Alkeran
    Indication: Multiple Myeloma
    Start date: 2000-01-01
    End date: 2000-01-01

Bicnu
    Indication: Multiple Myeloma
    Start date: 2000-01-01
    End date: 2000-01-01

Cyclophosphamide
    Indication: Multiple Myeloma
    Start date: 2000-01-01
    End date: 2000-01-01

Dexamethasone
    Indication: Multiple Myeloma
    Start date: 2004-01-01
    End date: 2008-01-01

Dexamethasone
    Start date: 2008-04-08
    End date: 2008-09-01

Doxorubicin Hydrochloride
    Indication: Multiple Myeloma
    Start date: 2000-01-01
    End date: 2000-01-01

Prednisone
    Indication: Multiple Myeloma
    Start date: 2000-01-01
    End date: 2000-01-01

Velcade
    Indication: Multiple Myeloma
    Start date: 2008-04-08
    End date: 2008-06-01

Vepesid
    Indication: Multiple Myeloma
    Start date: 2000-01-01
    End date: 2000-01-01

Vincristine
    Indication: Multiple Myeloma
    Start date: 2000-01-01
    End date: 2000-01-01

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017